CDT Equity Inc. (CDT)
NASDAQ: CDT · Real-Time Price · USD
3.110
-0.310 (-9.06%)
At close: Aug 10, 2026, 4:00 PM EDT
3.190
+0.080 (2.57%)
After-hours: Aug 10, 2026, 7:53 PM EDT
CDT Equity Employees
CDT Equity had 4 employees as of December 31, 2025. The number of employees decreased by 2 or -33.33% compared to the previous year.
Employees
4
Change (1Y)
-2
Growth (1Y)
-33.33%
Revenue / Employee
n/a
Profits / Employee
-$9,633,500
Market Cap
1.96M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 4 | -2 | -33.33% |
| Dec 31, 2024 | 6 | -1 | -14.29% |
| Dec 31, 2023 | 7 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Calidi Biotherapeutics | 29 |
| Virax Biolabs Group | 26 |
| Moleculin Biotech | 17 |
| Azitra | 13 |
| Genprex | 13 |
| Decoy Therapeutics | 11 |
| Artelo Biosciences | 7 |
| GRI Bio | 4 |
CDT News
- 7 days ago - CDT Increases Stake in Sarborg following its Quantum Computing and Intellectual Property Expansion - GlobeNewsWire
- 21 days ago - CDT Highlights Sarborg's Patent Filing Extending Quantum-Enabled PRISM Platform to Sugarcane - GlobeNewsWire
- 24 days ago - CDT Equity Inc trading halted, news pending - TheFly
- 25 days ago - CDT Equity announces 1-for-10 reverse stock split - TheFly
- 25 days ago - CDT Equity Inc. Announces Reverse Stock Split - GlobeNewsWire
- 6 weeks ago - CDT Highlights Sarborg's Application of Quantum Computing to Solid-Form Development - GlobeNewsWire
- 7 weeks ago - CDT Equity notes investment into Sarborg, expansion into quantum computing - TheFly
- 7 weeks ago - CDT Notes Strategic Investment into Sarborg and Expansion into Quantum Computing - GlobeNewsWire